Quickly
Socially
Trending
CryptoADAR POONAWALLA
COVID-19 Spike in China News Concerning, India Need Not to Panic Given Excellent Vaccination Coverage: Adar Poonawalla
COVID-19 Vaccine Update: Serum Institute of India Will Try To Launch Omicron-Specific Vaccine After Six Months, Says Adar Poonawalla
Cervical Cancer Vaccine to Be Launched in Few Months at Affordable Price, Says SII CEO Adar Poonawalla
Adar Poonawalla Suggests Elon Musk to Manufacture Tesla in India, Says ‘Best Investment You’ll Ever Make’
COVID-19 Vaccine: 'Covovax Will Be Used for Children; First Time Made in India Vaccine Sold in Europe', Says Adar Poonawalla
COVID-19 Booster Dose in India: Will Propose 6-Month Gap Between Dose 2 and 3, Says Adar Poonawalla
COVID-19 Vaccine Booster Dose Price in India: Serum Institute of India Revises Covishield Price From Rs 600 to Rs 225 per Dose for Private Hospitals
DCGI's EUA Nod to SII's Covovax For 12-17 Years Age Group; Adar Poonawalla Says Younger Age Groups to Follow Shortly
COVID-19 Vaccination: Bedridden Man in Jharkhand Starts Walking, Speaking After Covishield Dose, Claim Doctors
COVID-19 Vaccine Update: Covovax, Vaccine Produced By Serum Institute of India Under License From Novavax, Gets Emergency Use Approval From WHO
Covovax, COVID-19 Vaccine Produced By Serum Institute of India Under Licence From Novavax, Gets WHO Approval For Emergency Use
Google Trends
Live Bot